Skip to content
Contact
Algeria - National academic platform
...

Home › Researcher directory › Arsène MEKINIAN

Arsène MEKINIAN

Affiliation : Inserm · Sorbonne Université · Assistance Publique – Hôpitaux de Paris · Hôpital Saint-Antoine · Institut des Maladies Génétiques Imagine

  • 16Publications (affiliation in France)
  • 950Total publications
  • 16595Citations
  • 67h-index

Research profile

Arsène MEKINIAN has 16 indexed publications (2017–2026). Their work appears mainly in “Bone Marrow Transplantation”, “Journal of Neurology” and “Lara D. Veeken”. Their most cited article, “Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review” (2018), has been cited 92 times. 10 of these publications date from the last three years of activity. Their work is co-authored with at least 12 researchers, including institutions in Tunisia, United States.

Is this you? Get your research seen

Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.

Create my free profile Add my publications

Research areas

  • Vasculitis and related conditions
  • Systemic Lupus Erythematosus Research
  • Systemic Sclerosis and Related Diseases
  • Acute Myeloid Leukemia Research
  • Immunodeficiency and Autoimmune Disorders

Publications (16)

Publication venues

  • Bone Marrow Transplantation × 2
  • Journal of Neurology × 2
  • Lara D. Veeken × 2
  • La Revue de Médecine Interne × 2
  • Autoimmunity Reviews × 2
  • Arthritis & Rheumatology × 1

Publications per year

  • 20262
  • 20255
  • 20243
  • 20233
  • 20211
  • 20181
  • 20171

Collaborations

Partner institutions : Université Paris Cité · Hôpital de la Timone · Aix-Marseille Université · Hôpital Cochin · Hôpital Bichat-Claude-Bernard

Co-authors’ countries : Tunisia · United States

Co-authors

Bibliographic data from OpenAlex (open database).

Your research deserves to be discovered.

Give my research greater visibility →